Indoleamine 2,3-dioxygenase 1 (IDO1) activity arrests the apoptosis of Mycobacterium tuberculosis (M. tuberculosis)-infected macrophages Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021
Endogenous indoleamine 2,3-dioxygenase activity reduces local inflammatory cell numbers Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Increased Indoleamine 2,3-dioxygenase (IDO) activity as predictors of severity and outcome in patients with pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
Airway epithelial expression of indoleamine 2,3-dioxygenase and resolution of local inflammatory cells Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007
In vitro and in vivo activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of Mycobacterium tuberculosis (M. tb )Source: Eur Respir J 2005; 26: Suppl. 49, 700s Year: 2005
In-vitro effect of bioactive fractions of Cinnamomum verum(Cv) on cytokine levels in Mycobacterium tuberculosis (MTB) infected Macrophages. Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Indoleamine 2,3-dioxygenase in lung allograft tolerance Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009
In vitro activity of triclosan ( TCN ) and thiolactomycin ( TLM ) against multi-drug-resistant ( MDR ) strains of mycobacterium tuberculosis ( M. tb ) Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis -infected human macrophages Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018 Year: 2019
A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in miceSource: International Congress 2014 – Animal models in respiratory drug development Year: 2014
In vitro and vivo study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of mycobacterium tuberculosis (M.tb)Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Transcriptional expression of human telomerase reverse transcriptase (hTERT) and indoleamine 2,3-dioxygenase (IDO) in non-small cell lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Increased cell expression of CCR5 during M. tuberculosis infection Source: ISSN=ISSN 1810-6838, ISBN=, page=177 Year: 2005
Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008
The study of differential gene expression of matrix metalloproteinases in macrophages infected with Mycobacterium tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Assessment of differential activity of reactive radicals in cell lines infected with Mycobacterium tuberculosis . Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Different antimycobacterial activity of macrophages in various lung tuberculosis legions of patients Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020